Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: HongkongFázis nélkül

Efficacy of Cognitive Behavioural Therapy for Insomnia and Bright Light Therapy in Adolescents With ADHD, Insomnia, and Evening Chronotype

A legfontosabb adatok

Ki végzi
The University of Hong Kong
Hol
Hong Kong (Hongkong)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
150 fő, tervezett
Kezdés
2026. aug. 10.
Várható befejezés
2029. aug. 31.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
A vizsgált kezelések
  • CBT-I with Bright Light Group
  • CBT-I with Placebo Light Group
A regiszteradat frissítve
2026. augusztus 24.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for young people aged 10-24 years with ADHD, insomnia (trouble sleeping) and a late body clock (evening type). It tests group sleep therapy (CBT-I) with or without morning bright light therapy.

Életkor
10-24 years
Nem
All sexes
A betegség stádiuma
ADHD confirmed by DISC-IV. Insomnia disorder by DSM-5, with a score of ≥ 9. Evening type on the MEQ questionnaire, with late sleep onset on at least 3 nights per week in the past 3 months, confirmed by a 7-day sleep diary. Late sleep onset means 11:15pm or later at age 12, 11:30pm or later at 13-14, 12:00am or later at 15-17, and 10:56pm or later at 18-24.
Korábbi kezelés
People can join if they take no ADHD medicine, or if their ADHD medicine has been stable for at least 6 months. They cannot be in ongoing psychological treatment for sleep problems.

A részvétel fő kizáró okai

  • Substance abuse or dependence, or a current or past history of mania or hypomania, schizophrenia, autism (ASD), organic mental disorders or intellectual disability
  • A major medical condition that affects sleep (for example severe eczema, GERD) or another diagnosed sleep disorder, such as narcolepsy, breathing problems during sleep or restless leg syndrome
  • Regular use of medicines that affect sleep, such as hypnotics, steroids, melatonin or Traditional Chinese Medicine (ADHD stimulants are allowed)
  • Hearing or speech problems
  • Serious suicidal thoughts with a plan, or a suicide attempt

A regiszter feltételei, szó szerint

Mind a 16 feltétel megnézéseKevesebb

Ki vehet részt

  • An adolescent who meets the following criteria will be eligible for taking part in this study:
  • aged 10-24 years old
  • ADHD diagnosis confirmed by DISC-IV
  • DSM-5 diagnosis of insomnia disorder with an ≥ 9 (suggested cut-off for adolescents)
  • Being classified as evening chronotype according to the score on the Horne-Östberg Morning-Eveningness Questionnaire (MEQ) and having a sleep onset time of 11:15pm or later for 12 year olds, 11:30pm or later for 13-14 year olds, 12:00am or later for 15-17 years old [64], 10:56pm or later for 18-24 years old at least 3 nights per week in the past 3 months and as confirmed by a 7-day sleep diary
  • Written informed consent from the participant and their parent/guardian (for those aged under 18)
  • Being able to comply with the study protocol
  • Either not on ADHD medication or stabilized on medications for at least 6 months

Ki nem vehet részt

  • Concurrent, regular use of medications(s) known to affect sleep continuity and quality including both prescribed medications (e.g., hypnotics, steroids) and over-the-counter OTC medications (e.g., melatonin, Traditional Chinese Medicine, TCM), except for ADHD stimulants
  • Substance abuse or dependence; a current or past history of manic or hypomanic episode, schizophrenia, ASD, organic mental disorders, or intellectual disabilities
  • Prominent medical condition affecting sleep (e.g., severe eczema, GERD)
  • Clinically diagnosed sleep disorder other than insomnia disorder, such as narcolepsy, sleep-disordered breathing, and restless leg syndrome
  • An adolescent who meets one or more of the following criteria will be excluded from the study:
  • Ongoing psychological treatment for sleep problems
  • With hearing or speech deficit
  • Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt)

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 10 és 24 év között vagy?

Helyszínek itt: Hongkong

  • Sleep Research Clinic & Laboratory, Department of Psychology, The University of Hong Kong, Hong Kong,Hong Kong, HongkongContact: Shirley Xin Li Dr., DClinPsyToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by persistent inattention, hyperactivity, and impulsivity. In adolescents and young people, ADHD is commonly accompanied by insomnia and circadian delay. These co-occurring sleep and circadian disturbances may negatively affect daytime functioning and overall clinical outcomes. Although cognitive behavioural therapy for insomnia (CBT-I) is considered the first-line treatment for insomnia, and bright light therapy may help address circadian issues, their efficacy in adolescents with ADHD and comorbid insomnia and eveningness remains unexplored. This study aims to evaluate whether CBT-I, with or without bright light therapy, improves insomnia, sleep, and circadian as well as other clinical outcomes, and cognitive functioning in youths with ADHD and whether these interventions can also lead to improvements in mood and other clinical symptoms, as well as cognitive functioning.

A vizsgálat 3 csoportja

  • CBT-I with Bright Light TherapyA vizsgált kezelés

    The intervention for the CBT-I plus bright light therapy group will involve six weekly 90-minute group-based, face-to-face sessions of CBT-I, together with daily home-based morning bright light therapy starting from week 2. The CBT-I components are designed to address the behavioural, cognitive, and physiological factors that perpetuate insomnia while taking into account the sleep and circadian features of adolescents with ADHD, and include psychoeducation about sleep, circadian rhythm, and sleep hygiene, stimulus control, sleep restriction, relaxation training, structured worry time, cognitive restructuring, and relapse prevention. Bright light therapy will be administered at home using a portable light device for 30 minutes each morning, with timing individually determined and adjusted according to weekly sleep diary data.

    Kezelés: CBT-I with Bright Light Group

  • CBT-I with Placebo Light TherapyA vizsgált kezelés

    The intervention for the CBT-I plus placebo light therapy group will involve six weekly 90-minute group-based, face-to-face sessions of CBT-I delivered, together with daily home-based morning placebo light therapy starting from week 2. The CBT-I components are designed to address the behavioural, cognitive, and physiological factors that perpetuate insomnia while taking into account the sleep and circadian features of adolescents with ADHD and include psychoeducation about sleep, circadian rhythm, and sleep hygiene, stimulus control, sleep restriction, relaxation training, structured worry time, cognitive restructuring, and relapse prevention. Placebo light therapy will be administered at home using a portable placebo light device for 30 minutes each morning, with timing individually determined and adjusted according to weekly sleep diary data.

    Kezelés: CBT-I with Placebo Light Group

  • Waitlist controlNincs vizsgálati kezelés, összehasonlításként

    Participants in the waiting-list control group will not receive any active intervention during the study period but will complete the same set of assessments as the intervention groups at baseline and at post-waiting. This group will serve as a comparator for evaluating changes in outcomes over time. Participants will continue with their usual care and clinical follow-up as appropriate during the waiting period.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Efficacy of Cognitive Behavioural Therapy for Insomnia and Bright Light Therapy in Adolescents With ADHD and Comorbid Insomnia and Evening Chronotype: A Randomised, Assessor Blind, Parallel-group Trial
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Kérdések a feltételekről
Forrás: NCT07767617: ki vehet részt
A regiszteradat frissítve
2026. augusztus 24.